Fifteen-year experience with minimally invasive approach for reoperations involving the mitral valve

Joseph M Arcidi1, Evelio Rodriguez, Joseph R Elbeery

  • 1Department of Cardiovascular Sciences, East Carolina University, 600 Moye Blvd, Greenville, NC 27858, USA.

Abstract

Insights

Minimally invasive right thoracotomy is a safe and effective alternative to sternotomy for mitral valve reoperations, reducing mortality and stroke risk. This approach, utilizing fibrillatory or cardioplegic arrest, demonstrates improved outcomes over 15 years.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Minimally Invasive Procedures

Background:

  • Reoperative sternotomy for mitral valve pathology poses significant risks, particularly with prior bypass grafts or aortic valve prostheses.
  • Minimally invasive right thoracotomy with peripheral cannulation offers an alternative strategy to avoid sternotomy risks.

Purpose of the Study:

  • To review cumulative 15-year hospital outcomes of minimally invasive right thoracotomy for mitral valve reoperations.
  • To assess the safety and effectiveness of this approach compared to traditional sternotomy.

Main Methods:

  • A retrospective review of 167 patients undergoing right minithoracotomy for mitral valve reoperations between June 1996 and April 2010.
  • Analysis of patient demographics, previous surgical history, myocardial preservation techniques (fibrillatory arrest vs. aortic clamping/cardioplegia), and robotic assistance.
  • Evaluation of procedural outcomes, including mitral repair rates, concomitant procedures, mortality, stroke, and conversions to sternotomy.

Main Results:

  • Mitral repair frequency increased significantly over time (43% to 72%), especially for native valves (80%).
  • Concomitant procedures, such as atrial fibrillation ablation, also increased (0% to 48%).
  • Thirty-day mortality was 3.0% overall, with 0% reported since 2005. Stroke occurred in 2.4% of patients. Increased NYHA functional class was the only independent predictor of mortality.

Conclusions:

  • Minimally invasive right thoracotomy is an effective strategy for treating mitral valve pathology, successfully avoiding the risks associated with reoperative sternotomy.
  • Both fibrillatory and cardioplegic arrest methods are safe myocardial preservation techniques for this minimally invasive approach.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...